FDA approves first herbal medicine for trials on COVID-19

The Food and Drugs Authority has approved herbal medicine, Nibima for clinical trials and treatment of Covid-19.

A statement issued by the Authority said in search for a treatment for the virus, he School of Public Health at the Kwame Nkrumah University of Science and Technology submitted a clinical trial application for the herbal medicine in September 2020.

It said trials has shown that they are some clinical benefits from the drug.

Read the full statement below

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.